Recent Finacing
Recent Raise
Tau Therapeutics is an oncology company developing T-type calcium channel inhibitors and Interlaced Therapy, testing mibefradil sequentially with cytotoxic agents in a Phase 1b trial for recurrent high-grade glioma.
Focus Areas
Total Raised
Funding round